# Methadone as an Alternative Treatment for Children Underdoing HSCT

> **NCT06940570** · PHASE3 · SUSPENDED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Leukemia
- Aplastic Anemia
- Bone Marrow Failure Syndromes
- SCID

## Interventions

- **DRUG:** PCA plus methadone (Experimental)
- **DRUG:** PCA Alone (SOC)

## Key facts

- **NCT ID:** NCT06940570
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2028-01-01
- **Primary completion:** 2029-08
- **Final completion:** 2029-08-01
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** Study is closed with the IRB due to no funding. May resume once funding is obtained.
- **Last updated:** 2025-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06940570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06940570, "Methadone as an Alternative Treatment for Children Underdoing HSCT". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06940570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*